Ibrahim, N.K.; Eraky, A.; Eggers, J.; Steiert, T.A.; Sebens, S.; Jünemann, K.-P.; Hendricks, A.; Bang, C.; Stanulla, M.; Franke, A.;
et al. Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients. Cancers 2022, 14, 969.
https://doi.org/10.3390/cancers14040969
AMA Style
Ibrahim NK, Eraky A, Eggers J, Steiert TA, Sebens S, Jünemann K-P, Hendricks A, Bang C, Stanulla M, Franke A,
et al. Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients. Cancers. 2022; 14(4):969.
https://doi.org/10.3390/cancers14040969
Chicago/Turabian Style
Ibrahim, Nurul Khalida, Ahmed Eraky, Jan Eggers, Tim Alexander Steiert, Susanne Sebens, Klaus-Peter Jünemann, Alexander Hendricks, Corinna Bang, Martin Stanulla, Andre Franke,
and et al. 2022. "Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients" Cancers 14, no. 4: 969.
https://doi.org/10.3390/cancers14040969
APA Style
Ibrahim, N. K., Eraky, A., Eggers, J., Steiert, T. A., Sebens, S., Jünemann, K.-P., Hendricks, A., Bang, C., Stanulla, M., Franke, A., Hamann, C., Röcken, C., Arnold, N., Hinze, L., & Forster, M.
(2022). Detection of Cancer Mutations by Urine Liquid Biopsy as a Potential Tool in the Clinical Management of Bladder Cancer Patients. Cancers, 14(4), 969.
https://doi.org/10.3390/cancers14040969
